Contents
Why TTM Matters on the CCRN
- Post-cardiac-arrest care is a high-acuity cardiovascular/multisystem blueprint topic
- TTM questions test PHASES: who qualifies, how to cool, how to manage shivering, and how to rewarm safely
- The potassium-shift-with-temperature concept is a classic physiology trap
- Neuroprognostication timing (≥72 hours) shows up in ethics- and family-communication stems
Who Gets TTM?
- Adults with ROSC after cardiac arrest who remain COMATOSE (not following commands)
- Applies to shockable AND non-shockable rhythms, in- and out-of-hospital arrest
- Goal: limit secondary anoxic brain injury — fever after arrest worsens neurologic outcome
- Target: continuous temperature control at 32–36°C (commonly 33°C or 36°C per protocol) for at least 24 hours
- After rewarming: actively PREVENT fever for at least 72 hours post-arrest
The Three Phases: Induction, Maintenance, Rewarming
- Induction: reach target fast — surface pads or intravascular catheters with automated feedback control
- Maintenance: hold target with minimal fluctuation (±0.2–0.5°C) for ≥24 hours
- Rewarming: SLOW and controlled — 0.25–0.5°C per hour; rapid rewarming causes vasodilation, hypotension, and rebound cerebral edema
- Use a CORE temperature source: esophageal probe is most reliable; bladder works with adequate urine output; rectal lags behind
- Avoid rebound hyperthermia after rewarming — it undoes the neuroprotection
Test what you just learnedJump to CCRN-style practice questions on this topic — instant feedback with full rationales.
Start Free Practice →Shivering: The Enemy of Cooling
- Shivering generates heat and TRIPLES metabolic and oxygen demand — it defeats the therapy
- Assess with the Bedside Shivering Assessment Scale (BSAS)
- Stepwise control: acetaminophen, buspirone, magnesium (raises the shivering threshold), skin counterwarming of hands/feet/face
- Escalate: opioids (meperidine is classic but use caution), deeper sedation, then neuromuscular blockade LAST
- If paralyzed: deep sedation is MANDATORY, monitor train-of-four, and remember NMBs mask seizures — consider continuous EEG
Physiology of Cooling: The Exam Traps
- Bradycardia is expected and usually benign — do not treat unless hypotension or instability
- Cold diuresis: hypothermia triggers large urine output → hypovolemia + losses of K⁺, Mg₂⁺, and phosphate
- Potassium shifts INTO cells during cooling — replace cautiously (many protocols tolerate K⁺ ~3.0–3.5) because rewarming shifts it BACK OUT → rebound hyperkalemia
- Insulin resistance → hyperglycemia during cooling; insulin sensitivity RETURNS on rewarming → hypoglycemia risk
- Drug metabolism slows — sedatives and analgesics last longer (this also confounds early neuro exams)
- Mild coagulopathy and higher infection risk (cooling masks fever) — monitor cultures and wounds closely
Nursing Priorities During TTM
- Continuous core temp with a SECOND temperature source as backup — device malfunction happens
- Hourly neuro checks within the limits of sedation; document pupil response
- Skin assessment under cooling pads every 1–2 hours — thermal injury and breakdown are real risks
- Analgesia AND sedation before paralytics — a cold, paralyzed, awake patient is a never-event
- Strict I&O (cold diuresis), electrolytes q4–6h, glucose checks, and MAP support per orders
Rewarming: Where Patients Crash
- Rewarm at 0.25–0.5°C/hr — never 'just turn the device off'
- Vasodilation → hypotension: anticipate fluids/vasopressor titration
- Potassium exits cells → rebound hyperkalemia: hold aggressive K⁺ replacement late in cooling and recheck through rewarming
- Watch glucose closely — insulin needs FALL as sensitivity returns
- After target normothermia: continue fever prevention and slow sedation weaning before neuro assessment
Neuroprognostication: Timing Is Everything
- Formal neurologic prognostication is delayed until ≥72 hours after return to normothermia
- Sedatives, paralytics, and slowed drug clearance from hypothermia all confound early exams
- Multimodal approach: clinical exam, EEG, SSEPs, imaging, biomarkers — never a single test
- Nursing role: protect the family from premature conclusions and support structured communication
- Ethics stems: advocate for adequate time and data before withdrawal-of-care discussions
Can you answer these 3 CCRN questions?
Here are 3 questions in the style of our premium bank. The full rationale explains exactly why the right answer is right — and why the distractors trap most test-takers.
Premium Practice Question
During the maintenance phase of TTM at 33°C, the patient's potassium is 3.2 mEq/L. Why does the provider order only cautious partial replacement?
- Hypothermia causes potassium wasting through the GI tract
- Potassium will shift back out of cells during rewarming, risking rebound hyperkalemia
- Potassium is inactive at low body temperatures
- The level is falsely low due to cold agglutinins
Rationale: Cooling drives potassium intracellularly, so serum levels underestimate total body potassium. Aggressive replacement during cooling causes dangerous rebound hyperkalemia when rewarming shifts K⁺ back into the serum....
Unlock full rationale + 692 more questions
Premium Practice Question
A TTM patient at target temperature has a BSAS score of 2 (moderate shivering). Which intervention should come BEFORE neuromuscular blockade?
- Immediate cisatracurium bolus
- Skin counterwarming, acetaminophen, and magnesium per the shivering protocol
- Discontinue cooling until shivering stops
- Naloxone to reverse opioid rigidity
Rationale: Shivering is managed stepwise: acetaminophen, buspirone, magnesium, counterwarming, opioids, and deeper sedation all come before paralysis. NMBs are last-line and require deep sedation plus train-of-four monitoring....
Unlock full rationale + 692 more questions
Premium Practice Question
During rewarming from 33°C, the patient's MAP falls from 78 to 55 mmHg. What is the most likely cause?
- Rebound intracellular potassium shift
- Systemic vasodilation from rising temperature
- Cold diuresis
- Overshoot hypothermia
Rationale: Rewarming reverses cold-induced vasoconstriction; the resulting vasodilation drops preload and MAP. This is why rewarming is limited to 0.25–0.5°C/hr with fluids and vasopressors ready....
Unlock full rationale + 692 more questions
Related CCRN Guides
Frequently Asked Questions
Who qualifies for targeted temperature management?
Adults who achieve return of spontaneous circulation (ROSC) after cardiac arrest but remain comatose (not following commands) — regardless of initial rhythm or arrest location. The goal is to limit secondary anoxic brain injury and strictly prevent fever.
What temperature is targeted and for how long?
A constant target between 32–36°C (most protocols choose 33°C or 36°C) maintained for at least 24 hours, followed by slow rewarming and active fever prevention for at least 72 hours after arrest.
How fast should a TTM patient be rewarmed?
Slowly and in a controlled fashion: 0.25–0.5°C per hour. Rapid rewarming causes vasodilation with hypotension, rebound cerebral edema, and rebound hyperkalemia as potassium shifts back out of cells.
Why is shivering such a problem during TTM?
Shivering generates heat and dramatically increases metabolic and oxygen demand, directly fighting the therapy. It is managed stepwise — acetaminophen, buspirone, magnesium, skin counterwarming, opioids, sedation — with neuromuscular blockade only as a last resort under deep sedation.
Why is bradycardia during cooling usually left untreated?
Hypothermia slows the sinus node; heart rates in the 40s–50s are an expected physiologic response at 33°C and typically perfuse adequately. Treatment is only indicated if the bradycardia causes hypotension or instability.
Want the full CCRN experience?
Practice with 695+ exam-style questions, adaptive flashcards, and AI-powered weak-area drilling inside the Zero Deficit app.
Start Free →